| Phase I Study of Weekly Intravenous PS-341 (Bortezomib) Plus Mitoxantrone (NCT00059631) | M.D. Anderson Cancer Center | 2003-03-20 |
| Intensity Modulated Radiotherapy (IMRT) for the Pelvis Post-Hysterectomy (NCT00508703) | M.D. Anderson Cancer Center | 2003-03-05 |
| Procrit Versus No Procrit in Acute Lymphocytic Leukemia, Lymphoblastic Lymphoma, or Burkitt's Undergoing Induction/Consolidation Chemotherapy (NCT01099202) | M.D. Anderson Cancer Center | 2003-03-01 |
| Irinotecan and Cisplatin for High Grade Neuroendocrine Carcinoma of the Gastrointestinal Tract (NCT00353015) | M.D. Anderson Cancer Center | 2003-03-01 |
| Phase I Study of IV DOTAP: Cholesterol-Fus1 in Non-Small-Cell Lung Cancer (NCT00059605) | M.D. Anderson Cancer Center | 2003-03-01 |
| Autologous and Allogenic Transplantation With Campath-1H for T-Cell Lymphoma (NCT00505921) | M.D. Anderson Cancer Center | 2003-03-01 |
| Irinotecan (Camptosar) in Patients With Advanced Sarcomas (NCT00509860) | M.D. Anderson Cancer Center | 2003-03-01 |
| Juice Plus+ and Juice Plus+ Complete in Ovarian Cancer (NCT01439659) | M.D. Anderson Cancer Center | 2003-02-18 |
| Imatinib Mesylate, Busulfan, Fludarabine, and Antithymocyte Globulin for CML Patients (NCT00499889) | M.D. Anderson Cancer Center | 2003-02-01 |
| Evaluating the Use of Fibrin Tissue Adhesive in Melanoma Patients (NCT00506311) | M.D. Anderson Cancer Center | 2003-02-01 |
| Exercise Program for Adolescents and Young Adults With Cancer (NCT00502749) | M.D. Anderson Cancer Center | 2003-02-01 |
| Tissue Repair in Stem Cell Transplant Recipients (NCT00501228) | M.D. Anderson Cancer Center | 2003-02-01 |
| Intermittent Use of Aerosolized Ribavirin for Treatment of RSV (NCT00500578) | M.D. Anderson Cancer Center | 2003-02-01 |
| 3-Dimensional Form and Soft Tissue Biomechanics of the Breast (NCT00502814) | M.D. Anderson Cancer Center | 2003-01-01 |
| Chemoimmunotherapy Study for Patients With Epithelial Ovarian Cancer (NCT00501644) | M.D. Anderson Cancer Center | 2003-01-01 |
| In Vivo Confocal Imaging of Oral Mucosa (NCT00502125) | M.D. Anderson Cancer Center | 2003-01-01 |
| Post-Operative Chemoradiation for Extremity & Trunk Soft Tissue Sarcoma (NCT00502411) | M.D. Anderson Cancer Center | 2003-01-01 |
| Simple Versus Radical Hysterectomy for Stage I Cervical Cancer (NCT00506376) | M.D. Anderson Cancer Center | 2003-01-01 |
| Pain Quantification and Pain Management in Interventional Radiology (IR) (NCT00500942) | M.D. Anderson Cancer Center | 2003-01-01 |
| Depression Treatment and Screening in Ovarian Cancer Patients (NCT00515372) | M.D. Anderson Cancer Center | 2002-12-20 |
| Cardiomyopathy Tissue Bank in a Cancer Population (NCT00500734) | M.D. Anderson Cancer Center | 2002-12-10 |
| Study of ABT-751 in Patients With Refractory Hematologic Malignancies (NCT00047489) | M.D. Anderson Cancer Center | 2002-12-01 |
| Phase I/II Evaluation of Temozolomide and ZARNESTRA (R115777) for Recurrent and Progressive Glioblastoma Multiforme (NCT00050986) | M.D. Anderson Cancer Center | 2002-12-01 |
| Cyclophosphamide, Fludarabine, Alemtuzumab, and Rituximab (CFAR) for Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL) (NCT01082939) | M.D. Anderson Cancer Center | 2002-12-01 |
| Celecoxib in Preventing Colorectal Cancer in Young Patients With a Genetic Predisposition for Familial Adenomatous Polyposis (NCT00685568) | M.D. Anderson Cancer Center | 2002-11-21 |
| Melanoma Risk-Reduction Among Patients and Family Members (NCT00510302) | M.D. Anderson Cancer Center | 2002-11-18 |
| Assessment of Symptom-Related Cytokines in Lung and Gastrointestinal (GI) Cancer Patients (NCT00502502) | M.D. Anderson Cancer Center | 2002-11-01 |
| Study of Lonafarnib and Gleevec in Chronic Myelogenous Leukemia (NCT00047502) | M.D. Anderson Cancer Center | 2002-11-01 |
| Modified Hyper-CVAD (Cyclophosphamide, Vincristine, Adriamycin, and Dexamethasone) Program for Acute Lymphoblastic Leukemia (NCT00671658) | M.D. Anderson Cancer Center | 2002-11-01 |
| GnRH Analogue for Ovarian Function Preservation in Hematopoietic Stem Cell Transplantation Patients (NCT00429494) | M.D. Anderson Cancer Center | 2002-11-01 |
| Evaluation of Antiproliferative Effects of Arimidex in Ductal Lavage Fluid in Patients With Breast Cancer (NCT01207635) | M.D. Anderson Cancer Center | 2002-11-01 |
| Evaluation of Differing Taxanes/Taxane Combinations on the Outcome of Patients With Operable Breast Cancer (NCT00050167) | M.D. Anderson Cancer Center | 2002-11-01 |
| Evaluation of a Novel CT-On-Rails or Trilogy Stereotactic Spine Radiotherapy System (SSRS) (NCT00508443) | M.D. Anderson Cancer Center | 2002-10-25 |
| Safety and Efficacy of 90Y Zevalin in Nonmyeloablative Transplantation for Lymphoid Malignancies (NCT00048737) | M.D. Anderson Cancer Center | 2002-10-01 |
| Zarnestra and Gleevec in Chronic Phase Chronic Myelogenous Leukemia (NCT00040105) | M.D. Anderson Cancer Center | 2002-10-01 |
| Campath-1H Plus Rituximab for CD52- and CD20- Positive Refractory or Relapsed Chronic Lymphoid Disorders (NCT00071396) | M.D. Anderson Cancer Center | 2002-10-01 |
| Continuous Infusion of Campath-1H Followed by Subcutaneous Injections in Previously Treated Patients With Chronic Lymphocytic Leukemia (NCT00102661) | M.D. Anderson Cancer Center | 2002-10-01 |
| Sexual Functioning in Cervical Cancer Survivors (NCT00522223) | M.D. Anderson Cancer Center | 2002-09-10 |
| Measurement of Digital Colposcopy for Fluorescence Spectroscopy of Cervical Intraepithelial Neoplasia (NCT00513123) | M.D. Anderson Cancer Center | 2002-09-01 |
| Study of Combined RHUMAB VEGF and Capecitabine-based Chemoradiation for Patients With Locally Advanced Pancreatic Cancer (NCT00047710) | M.D. Anderson Cancer Center | 2002-09-01 |
| Lymphoscintigraphy in Patients With Vaginal Cancer (NCT00528034) | M.D. Anderson Cancer Center | 2002-09-01 |
| Interaction Between Patient and Healthcare Provider: Response to Acupuncture in Knee Osteoarthritis (NCT00059345) | M.D. Anderson Cancer Center | 2002-09-01 |
| Biobehavioral Effects of Emotional Expression in Cancer (NCT00505310) | M.D. Anderson Cancer Center | 2002-08-21 |
| Rituximab and Hyper-CVAD (Cyclophosphamide, Vincristine, Adriamycin, and Dexamethasone) for Burkitt's and Burkitt's -Like Leukemia/Lymphoma (NCT00669877) | M.D. Anderson Cancer Center | 2002-08-01 |
| Patient Controlled Administration of Methylphenidate for Cancer Related Fatigue - PRN Methylphenidate (NCT02361125) | M.D. Anderson Cancer Center | 2002-08-01 |
| Iressa/Docetaxel in Non-Small-Cell Lung Cancer (NCT00048087) | M.D. Anderson Cancer Center | 2002-08-01 |
| Herceptin and GM-CSF for Metastatic Breast Cancer (NCT00429104) | M.D. Anderson Cancer Center | 2002-08-01 |
| Avastin and Tarceva for Locally Advanced or Metastatic Non-Squamous Non-Small-Cell Lung Cancer (NCT00043823) | M.D. Anderson Cancer Center | 2002-08-01 |
| Study of Gelonin Purging of Autologous Stem Cells for Transplantation (NCT00043810) | M.D. Anderson Cancer Center | 2002-07-01 |
| PEG-Interferon Alfa-2b in Treating Patients With Platinum-Resistant Ovarian Epithelial, Peritoneal, or Fallopian Tube Cancer (NCT00085384) | M.D. Anderson Cancer Center | 2002-07-01 |
| Acupressure in Treating Nausea in Women Receiving Combination Chemotherapy for Breast Cancer (NCT00046865) | M.D. Anderson Cancer Center | 2002-07-01 |
| Pancreatic Cancer Genetic Epidemiology (PACGENE) Study (NCT00526578) | M.D. Anderson Cancer Center | 2002-06-19 |
| Fibrin Melanoma Axillary Node Study in Patients With Melanoma (NCT00504582) | M.D. Anderson Cancer Center | 2002-05-15 |
| Proteasome Inhibitor PS-341 Relapsed or Refractory B Cell Lymphomas Previously Treated With Chemotherapy (NCT00038571) | M.D. Anderson Cancer Center | 2002-05-01 |
| Hepatic Artery Infusion of CD34+ Cells (NCT00062543) | M.D. Anderson Cancer Center | 2002-05-01 |
| Chemotherapy, Interferon Alfa, and Radiation Therapy in Treating Patients Who Have Undergone Surgery For Pancreatic Cancer (NCT00068575) | M.D. Anderson Cancer Center | 2002-05-01 |
| Computer-Assisted Counseling in Helping African American Smokers Stop Smoking (NCT00310141) | M.D. Anderson Cancer Center | 2002-04-08 |
| Motivational Counseling in Preventing Smoking Relapse After Pregnancy in Pregnant Women Who Quit Smoking During Pregnancy (NCT00310115) | M.D. Anderson Cancer Center | 2002-04-01 |
| Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate Cancer (NCT00024167) | M.D. Anderson Cancer Center | 2002-04-01 |
| Study Of Yttrium-ibritumomab (Zevalin) For the Treatment Of Patients With Relapsed And Refractory Mantle Cell Lymphoma (NCT00038623) | M.D. Anderson Cancer Center | 2002-04-01 |
| Combined Colon and Endometrial Cancer Screening in Women With HNPCC (NCT00510796) | M.D. Anderson Cancer Center | 2002-03-01 |
| Gleevec Study for Patients With Ovarian Cancer (NCT00510653) | M.D. Anderson Cancer Center | 2002-03-01 |
| TMC (Topotecan, Cyclophosphamide and Melphalan) for Multiple Myeloma (NCT01039025) | M.D. Anderson Cancer Center | 2002-02-18 |
| Quality of Life Associated With a Low-Risk Screening Program for Ovarian Cancer (NCT00511641) | M.D. Anderson Cancer Center | 2002-02-12 |
| Aspirin in Patients With Myocardial Infarction and Thrombocytopenia (NCT00501345) | M.D. Anderson Cancer Center | 2002-02-01 |
| Identifying Genetic Markers That Predict Response to Paclitaxel in Patients With Newly Diagnosed Stage III or Stage IV Ovarian Epithelial Cancer or Primary Peritoneal Cancer (NCT00897806) | M.D. Anderson Cancer Center | 2002-02-01 |
| Malignant Mixed Mesodermal Tumor (MMMT) - Early Stage With Postoperative XRT/Chemotherapy (NCT00505492) | M.D. Anderson Cancer Center | 2002-02-01 |
| Doxorubicin and Strontium-89 With or Without Celecoxib in Treating Patients With Progressive Androgen-Independent Prostate Cancer and Bone Metastases (NCT00080782) | M.D. Anderson Cancer Center | 2002-02-01 |
| FM 140 vs FM100 Study in Patients With Multiple Myeloma (NCT00505895) | M.D. Anderson Cancer Center | 2002-01-01 |
| Prevalence of Secondary Hypogonadism in Male Patients on Chronic Opioid Therapy for Cancer-Related Pain Syndromes (NCT00529230) | M.D. Anderson Cancer Center | 2001-12-11 |
| PP-Gemcitabine & External Beam Radiation-Sarcomas (NCT02046304) | M.D. Anderson Cancer Center | 2001-12-01 |
| A Phase I/II Trial of Idiotypic Vaccination for Chronic Lymphocytic Leukemia Using a Genetic Approach (NCT00038415) | M.D. Anderson Cancer Center | 2001-12-01 |
| Alopecia Areata Registry (NCT00069589) | M.D. Anderson Cancer Center | 2001-11-01 |
| High Dose I-131 Metaiodobenzylguanidine(MIBG) for Metastatic Neuroendocrine Tumors (NCT00037869) | M.D. Anderson Cancer Center | 2001-11-01 |
| Reflectance Confocal Imaging in Cervical Cancer Patients (NCT00505726) | M.D. Anderson Cancer Center | 2001-11-01 |
| Celecoxib as a Chemopreventive Agent in Current and Former Smokers (NCT00981201) | M.D. Anderson Cancer Center | 2001-11-01 |
| Prophylactic Use of Filgrastim SD/01 in Patients With Hodgkin's Disease Receiving ABVD Chemotherapy (NCT00038558) | M.D. Anderson Cancer Center | 2001-11-01 |
| A Double-Blind, Randomized, Placebo-Controlled Study of the Efficacy and Safety of Weekly Procrit Given to Gastric or Rectal Patients (NCT00254436) | M.D. Anderson Cancer Center | 2001-10-31 |
| Study of Vioxx and Radiation Therapy for Brainstem Glioma (NCT00038389) | M.D. Anderson Cancer Center | 2001-10-01 |
| Phase I Trial of Fixed Dose STI571 (Imatinib Mesylate) With Escalating Doses of Docetaxel in Patients With Metastatic Androgen-Independent Prostate Cancer (NCT00038194) | M.D. Anderson Cancer Center | 2001-10-01 |
| Temozolomide and SCH66336 for Recurrent Glioblastoma Multiforme (NCT00038493) | M.D. Anderson Cancer Center | 2001-09-21 |
| Phase I Study of Continuous Infusion Schedule of FMdC in Hematologic Malignancies (NCT00061620) | M.D. Anderson Cancer Center | 2001-09-06 |
| Registry for Multiple Endocrine Neoplasia Syndromes: MEN1/MEN2 (NCT03048279) | M.D. Anderson Cancer Center | 2001-09-05 |
| Imatinib Mesylate in Treating Patients With Metastatic Melanoma (NCT00027586) | M.D. Anderson Cancer Center | 2001-09-01 |
| Mifepristone for Patients With Endometrial Cancer and LGESS (NCT00505739) | M.D. Anderson Cancer Center | 2001-09-01 |
| Megadose CD34 Selected Progenitor Cells for Transplantation in Patients With Advanced Hematological Malignant Diseases (NCT00038857) | M.D. Anderson Cancer Center | 2001-09-01 |
| Primary Breast Cancer Occurring Concomitant With Pregnancy (NCT00510367) | M.D. Anderson Cancer Center | 2001-08-07 |
| Nerve-Sparing Radical Prostatectomy With or Without Nerve Grafting Followed by Standard Therapy for Erectile Dysfunction in Treating Patients With Localized Prostate Cancer (NCT00080808) | M.D. Anderson Cancer Center | 2001-08-01 |
| Paclitaxel and Carboplatin in Women With Malignant Mixed Mullerian Tumors (MMMT) of the Uterus (NCT00502203) | M.D. Anderson Cancer Center | 2001-08-01 |
| Use of CA125 and Complementary Biomarkers for the Early Detection of Ovarian Cancer in Low Risk Women (NCT00539162) | M.D. Anderson Cancer Center | 2001-07-02 |
| Bortezomib in Treating Patients With Chronic Myelogenous Leukemia (NCT00023881) | M.D. Anderson Cancer Center | 2001-07-02 |
| Late Chronic Phase Chronic Myelogenous Leukemia (NCT01092741) | M.D. Anderson Cancer Center | 2001-07-01 |
| Neoadjuvant Ifosfamide, Doxorubicin, Gemcitabine, and Cisplatin in Treating Patients Who Are Undergoing Radical Cystectomy for Locally Advanced Carcinoma (Cancer) of the Urothelium (NCT00080795) | M.D. Anderson Cancer Center | 2001-07-01 |
| Therapy of Early Chronic Phase CML With Higher-Dose Gleevec, Alpha Interferon, and Low-Dose Ara-C (NCT00038649) | M.D. Anderson Cancer Center | 2001-06-01 |
| Trial of Primary Prophylaxis With rhTPO Administered to Patients With High Risk Sarcoma Receiving Intensive Chemotherapy (NCT00283582) | M.D. Anderson Cancer Center | 2001-06-01 |
| Therapy of HES, PV, Atypical Chronic Myelocytic Leukemia (CML) or Chronic Myelomonocytic Leukemia (CMML), and Mastocytosis With Imatinib Mesylate (NCT00038675) | M.D. Anderson Cancer Center | 2001-06-01 |
| Safety and Efficacy of Campath in Nonmyeloablative Transplantation (NCT00038844) | M.D. Anderson Cancer Center | 2001-06-01 |
| A Phase II Study of Paclitaxel and Topotecan With Filgrastim-SD/01 Support For Relapsed and Refractory Aggressive Non-Hodgkin's Lymphoma (NCT00038545) | M.D. Anderson Cancer Center | 2001-05-18 |
| CD8 DLI for Patients With Relapse or Residual Disease Following Allogeneic Stem Cell Transplantation (NCT00038818) | M.D. Anderson Cancer Center | 2001-05-01 |
| Nonmyeloablative Preparative Regimen Using Mylotarg for Patients With High Risk Acute Myeloid Leukemia (AML), Acute Lymphocytic Leukemia (ALL), Chronic Myeloid Leukemia (CML) and Myelodysplastic Syndrome (MDS) (NCT00038805) | M.D. Anderson Cancer Center | 2001-05-01 |